ArticleContemporary clinical trials communications2023

Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.

Lisa J Woodhouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.